Cell Medica

Cell Medica is a cell therapy company dedicated to developing new technologies for treating human diseases based on a treatment method known as cellular immunotherapy. This technology involves harnessing and enhancing the ability of the human immune system to combat diseases. The company's immunotherapy products are developed using three proprietary technology platforms, including activated cytotoxic T cells, chimeric antigen receptors (CAR), and engineered T-cell receptors (TCR), which reprogram human immune cells to identify and kill cancer cells while also preventing cancer escape mechanisms, enabling healthcare providers to treat infections, diabetes, spinal cord injuries, heart damage, and cancer.